GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (MIL:1SAN) » Definitions » Equity-to-Asset

Sanofi (MIL:1SAN) Equity-to-Asset : 0.56 (As of Jun. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sanofi Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sanofi's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €72,690 Mil. Sanofi's Total Assets for the quarter that ended in Jun. 2024 was €129,755 Mil. Therefore, Sanofi's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.56.

The historical rank and industry rank for Sanofi's Equity-to-Asset or its related term are showing as below:

MIL:1SAN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.5   Med: 0.57   Max: 0.59
Current: 0.56

During the past 13 years, the highest Equity to Asset Ratio of Sanofi was 0.59. The lowest was 0.50. And the median was 0.57.

MIL:1SAN's Equity-to-Asset is ranked worse than
54.84% of 1043 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs MIL:1SAN: 0.56

Sanofi Equity-to-Asset Historical Data

The historical data trend for Sanofi's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Equity-to-Asset Chart

Sanofi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.57 0.57 0.59 0.59

Sanofi Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.59 0.58 0.59 0.56

Competitive Comparison of Sanofi's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Sanofi's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sanofi's Equity-to-Asset falls into.



Sanofi Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sanofi's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=74040/126464
=0.59

Sanofi's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=72690/129755
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi  (MIL:1SAN) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sanofi Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sanofi's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Business Description

Address
46, avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Sanofi Headlines

No Headlines